Najat Khan - Chief R&D Commercial Officer, Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Commercial Officer, Director
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Najat Khan since 9/18/2023

Holdings reported by Najat Khan for Recursion Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 497K $4.04M $8.13 Aug 1, 2024 Direct
Stock Option (Right to Buy) 994K Aug 1, 2024 Direct Class A Common Stock

Transactions reported by Najat Khan for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.